Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents.
Joseph GracéDavid Ewan ConnorLourens BesterChristopher RoganKurosh ParsiPublished in: Phlebology (2023)
The commercially available medical cyanoacrylates differ in their polymerisation rates. These polymerisation rates are further affected when these products are used in conjunction with other compounds, such as sclero-embolic and contrast agents.